ID: ALA4547121

Max Phase: Preclinical

Molecular Formula: C12H12BrNO

Molecular Weight: 266.14

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C#CCN(Cc1ccc(Br)cc1)C(C)=O

Standard InChI:  InChI=1S/C12H12BrNO/c1-3-8-14(10(2)15)9-11-4-6-12(13)7-5-11/h1,4-7H,8-9H2,2H3

Standard InChI Key:  MSTQIMXHUGEUJI-UHFFFAOYSA-N

Associated Targets(Human)

Pyrroline-5-carboxylate reductase 1, mitochondrial 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 266.14Molecular Weight (Monoisotopic): 265.0102AlogP: 2.43#Rotatable Bonds: 3
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.14CX LogD: 2.14
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.77Np Likeness Score: -1.62

References

1. Milne K, Sun J, Zaal EA, Mowat J, Celie PHN, Fish A, Berkers CR, Forlani G, Loayza-Puch F, Jamieson C, Agami R..  (2019)  A fragment-like approach to PYCR1 inhibition.,  29  (18): [PMID:31362921] [10.1016/j.bmcl.2019.07.047]

Source